share_log

GeneTether Therapeutics Inc: ON FORM 13-502F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)

SEDAR ·  Apr 28, 2023 06:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more